819 Capital Partners and LIOF have invested in I-Med Technology (“I-Med”) in a substantial investment round. I-Med Technology develops and markets advanced head-mounted 3D imaging systems that provide real-time support, enhancing precision and efficiency in medical and dental procedures.
I-Med secures strategic investment to fuel 3D imaging expansion
I-Med Technology B.V., a cutting-edge medical technology company specializing in advanced 3D imaging systems for healthcare, announced today that it has secured an investment from 819 Capital Partners and LIOF, positioning the company for rapid growth and expanded market impact. Johan van de Ven, CEO of I-Med: "We are thrilled to partner with 819 Capital Partners and LIOF. Their support and investment enable us to move swiftly in bringing our technology to more clinicians and expanding our reach in the medical imaging market. This funding underscores the value of our innovation and allows us to continue pushing boundaries in medical visualization technology."
Revolutionizing surgery: I-Med’s 3D head-mounted microscope enhances precision and safety
Founded in 2018 and headquartered at the Brightlands Health Campus in Maastricht, I-Med is committed to addressing critical challenges in surgical and dental procedures where precision and speed are essential. Vincent Graham, CTO at I-Med: “Traditional 2D imaging techniques, often displayed away from the surgical field, require clinicians to shift focus frequently, impacting procedural efficiency. I-Med’s Digital Head-mounted Microscope offers a breakthrough solution with Full HD, real-time 3D imaging, mixed realities, enhancing precision and quality while providing a safer and more seamless operating experience.” Jaap Heukelom, CCO at i-Med Technology, adds: “Moreover, the system represents a leap forward for medical training, education and remote support applications and offers a powerful platform for artificial intelligence applications that can assist the surgeon and dentist alike in their clinical practice”.
Investment driving societal impact in healthcare through improved patient outcomes
819 Capital Partners has invested in I-Med from 819 Evergreen Fund I, a fund committed to investments in deep-tech and med-tech ventures. Sven Kempers, director at 819: “Our investment in I-Med aligns with our goal of advancing promising technology. We have great confidence in I-Med’s technology and its growth potential.”
LIOF has invested in I-Med from their Participation Fund, a fund committed for newly started and medium-sized, innovative SMEs who want to grow. Willem van Esch, investment manager at LIOF: “We see the potential in I-Med’s 3D imaging systems to redefine surgical precision and enhance patient care. Our support will help accelerate their impact across the healthcare sector, making advanced imaging more accessible and transforming the future of medical procedures.”
Comments